Search
forResearch 10 of 71
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- 0250 Systemic therapy associates with a lower incidence of male infertility among psoriasis patients
- 0441 Systemic autoimmune comorbidity in alopecia totalis and universalis compared with patchy alopecia areata: A retrospective cohort study
- LB923 A matched cohort study evaluating the risk of keloid development in alopecia areata patients
- No elevated risk for osteoporosis or osteopenia among women with androgenetic or frontal fribrosing alopecia treated with 5-alpha reductase inhibitors: A retrospective TriNetX cohort study
- MP74-11 TRENDS IN THE PHARMACOTHERAPY OF NOCTURIA, 2016-2021: ANALYSIS OF A LARGE MULTI-INSTITUTIONAL RESEARCH NETWORK
- The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Increased Incidence and Risk of Hair Loss with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Multicentre Cohort Study
- Beyond hair loss: Exploring the psychiatric burden of alopecia areata in a large cohort
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →